Across TCGA pan-cancer cohorts, SLC35F1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated SLC35F1 data layer compared with 24 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher SLC35F1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SLC35F1 expression acts as an unfavorable survival marker.

LUSC, LGG, and UCEC are the cancer types where SLC35F1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	III,IV	0.112	0.664	.020	12	view →
LGG	OS	Median	All	0.187	0.909	<.001	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: SLC35F1 tumor-vs-normal RNA expression · all SLC35F1 data types